Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects...

por Parker, Joseph M, Oh, Chad K, LaForce, Craig, Miller, S David, Pearlman, David S, Le, Chenxiong, Robbie, Gabriel J, White, Wendy I, White, Barbara, Molfino, Nestor A
Publicado 2011

The impact of exacerbation frequency on mortality following acute exacerbations of COPD: a registry-based cohort study

por Schmidt, Sigrun Alba Johannesdottir, Johansen, Martin Berg, Olsen, Morten, Xu, Xiao, Parker, Joseph M, Molfino, Nestor A, Lash, Timothy L, Sørensen, Henrik Toft, Christiansen, Christian Fynbo
Publicado 2014

Phase 2 clinical trial of PBI-4050 in patients with idiopathic pulmonary fibrosis

por Khalil, Nasreen, Manganas, Helene, Ryerson, Christopher J., Shapera, Shane, Cantin, Andre M., Hernandez, Paul, Turcotte, Eric E., Parker, Joseph M., Moran, John E., Albert, Gary R., Sawtell, Renata, Hagerimana, Aline, Laurin, Pierre, Gagnon, Lyne, Cesari, Frank, Kolb, Martin
Publicado 2019